We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Six-Year Survival Outcomes for Patients with HER2-Positive Early Breast Cancer Treated with CT-P6 or Reference Trastuzumab: Observational Follow-Up Study of a Phase 3 Randomised Controlled Trial.
- Authors
Stebbing, Justin; Baranau, Yauheni; Baryash, Valery; Moiseyenko, Vladimir; Boliukh, Dmytro; Antone, Nicoleta; Manikhas, Alexey; Chornobai, Anatolii; Park, Taehong; Baek, Eric Hyungseok; Lee, Jaeyong; Choi, Jiin; Kim, Nahyun; Ahn, Keumyoung; Lee, Sang Joon; Kim, Sunghyun
- Publication
BioDrugs, 2023, Vol 37, Issue 3, p433
- ISSN
1173-8804
- Publication type
Article
- DOI
10.1007/s40259-023-00582-w